CVS Health Corp (CVS · NYSE)
CVS · MARKET VIEW
Market view · as of Jul 20, 2026
Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
100.0%
0.0% vs 52w high · +8.4% 1mo
Price (last ~year)
CVS Health Corp (CVS) is trading at its 52-week high, up 40.1% over the last three months, following four consecutive quarterly earnings beats. The company reported TTM revenue of $405.62 billion, a 6.1% year-over-year increase, and a 63.1% rise in earnings. As of March 31, 2026, CVS maintains a market cap of $137.12 billion, with $78.34 billion in total debt and a 5.1x debt-to-EBITDA ratio against $3.40 billion in quarterly free cash flow.
Valuation
- Market cap
- $137.12B
- P/E
- 47.14
- PEG
- 0.302
- P/B
- 1.77
- P/S
- 0.338
- EV/EBITDA
- 18.3
- Beta
- 0.598
- Analyst target
- $111.92
Quality & returns
- Gross margin
- 13.4%
- Operating margin
- 4.1%
- Profit margin
- 0.7%
- ROE
- 3.8%
- ROA
- 2.7%
Price movement
- Last
- $107.47
- 1-month
- +8.4%
- 3-month
- +40.1%
- RSI (14)
- 61
- vs SMA200
- +30.6%
- 52-wk position
- 100.0% 0.0% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $100.43B | $4.68B | $2.94B | $5.83B |
| 2025-12-31 | $105.69B | $2.11B | $2.94B | $3.29B |
| 2025-09-30 | $102.87B | $-3.21B | $-3.98B | $-1.56B |
| 2025-06-30 | $98.92B | $2.38B | $1.02B | $3.58B |
Recent news
- Neutral CVS Health stock trades steadily as investors weigh solid revenue growth and Medicare Advantage head · 2026-07-20
- Bullish SEB Asset Management AB Takes $62.64 Million Position in CVS Health Corporation $CVS · 2026-07-19
- Bullish Swiss National Bank Has $267.56 Million Holdings in CVS Health Corporation $CVS · 2026-07-19
- Somewhat-Bullish Hanseatic Management Services Inc. Acquires Shares of 10,768 CVS Health Corporation $CVS · 2026-07-19
- Somewhat-Bullish California Public Employees Retirement System Acquires 269,363 Shares of CVS Health Corporation $CVS · 2026-07-19
- Neutral CVS Health stock holds steady on earnings context and 2025 guidance · 2026-07-19
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)